V

Veracyte
D

VCYT

39.230
USD
-1.82
(-4.43%)
مغلق
حجم التداول
35,942
الربح لكل سهم
1
العائد الربحي
-
P/E
-302
حجم السوق
3,040,310,446
أصول ذات صلة
    NEOUSD
    NEOUSD
    0.098
    (0.92%)
    10.676 USD
    C
    CDNA
    -1.050
    (-4.50%)
    22.290 USD
    E
    EXAS
    -0.270
    (-0.55%)
    49.250 USD
    F
    FGEN
    -0.09040
    (-11.70%)
    0.68200 USD
    G
    GH
    -4.510
    (-9.51%)
    42.910 USD
    ILMN
    ILMN
    -3.080
    (-3.17%)
    94.180 USD
    N
    NEO
    -0.735
    (-6.21%)
    11.100 USD
    R
    RGEN
    -3.710
    (-2.28%)
    158.950 USD
    T
    TDOC
    -1.190
    (-9.38%)
    11.490 USD
    T
    TNDM
    -1.110
    (-3.45%)
    31.020 USD
    V
    VEEV
    -2.960
    (-1.29%)
    225.900 USD
    المزيد
الأخبار المقالات

العنوان: Veracyte

القطاع: Healthcare
الصناعة: Diagnostics & Research
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.